Cancer Biomarkers

cancer biomarker refers to a constituent or method that is indicative of the existence of cancer in the body. A biomarker may be a molecule concealed by a tumour or a particular response of the body to the existence of cancer. Epigenetic, proteomic, genetic, glycomic, and imaging biomarkers can be recycled for cancer diagnosis, prognosis, and epidemiology. While some cancer biomarkers can be used to forecast how violently your cancer will grow, and are therefore useful for evaluating your prognosis, the most favourable use of biomarkers today is to recognize which therapies a patient’s cancer may or may not react to.

  • Diagnostic Biomarkers
  • Tumour Suppressors Biomarkers
  • Predictive & Prognostic Biomarkers
  • Companion Biomarker

Related Conference of Cancer Biomarkers

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
March 21-22, 2024

8th Global Meeting on Oncology and Radiology

Paris, France
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in